Cargando…

Cannabinoid Drugs-Related Neuroprotection as a Potential Therapeutic Tool Against Chemotherapy-Induced Cognitive Impairment

In recent years, and particularly associated with the increase of cancer patients’ life expectancy, the occurrence of cancer treatment sequelae, including cognitive impairments, has received considerable attention. Chemotherapy-induced cognitive impairments (CICI) can be observed not only during pha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boullon, Laura, Abalo, Raquel, Llorente-Berzal, Álvaro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632779/ https://www.ncbi.nlm.nih.gov/pubmed/34867342 http://dx.doi.org/10.3389/fphar.2021.734613

Ejemplares similares

Sex Differences in a Rat Model of Peripheral Neuropathic Pain and Associated Levels of Endogenous Cannabinoid Ligands
por: Boullon, Laura, et al.
Publicado: (2021)

Involvement of Cannabinoid Signaling in Vincristine-Induced Gastrointestinal Dysmotility in the Rat
por: Vera, Gema, et al.
Publicado: (2017)

Cannabinoids as Glial Cell Modulators in Ischemic Stroke: Implications for Neuroprotection
por: Vicente-Acosta, Andrés, et al.
Publicado: (2022)

Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?
por: Nurgali, Kulmira, et al.
Publicado: (2018)

Cannabinoids As Potential Treatment for Chemotherapy-Induced Nausea and Vomiting
por: Rock, Erin M., et al.
Publicado: (2016)

Chemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging Treatments
por: McQuade, Rachel M., et al.
Publicado: (2016)

Mechanisms of Chemotherapy-Induced Neurotoxicity
por: Was, Halina, et al.
Publicado: (2022)

Editorial: Therapeutic potential of the cannabinoid CB2 receptor
por: Smoum, Reem, et al.
Publicado: (2022)

Chocolate, Air Pollution and Children's Neuroprotection: What Cognition Tools should be at Hand to Evaluate Interventions?
por: Calderón-Garcidueñas, Lilian, et al.
Publicado: (2016)

Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses
por: Walsh, Kenneth B., et al.
Publicado: (2021)

The Binding Mode to Orthosteric Sites and/or Exosites Underlies the Therapeutic Potential of Drugs Targeting Cannabinoid CB(2) Receptors
por: Franco, Rafael, et al.
Publicado: (2022)

Editorial: Antioxidant and neuroprotective potential of alternative and complementary therapeutic approaches against Alzheimer’s disease
por: Singh, Sandeep Kumar, et al.
Publicado: (2023)

Therapeutic Drugs and Devices for Tackling Ocular Hypertension and Glaucoma, and Need for Neuroprotection and Cytoprotective Therapies
por: Sharif, Najam A.
Publicado: (2021)

Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain
por: Levin, Raquel, et al.
Publicado: (2014)

Mitragynine (Kratom)-Induced Cognitive Impairments in Mice Resemble Δ9-THC and Morphine Effects: Reversal by Cannabinoid CB(1) Receptor Antagonism
por: Iman, Ismail Nurul, et al.
Publicado: (2021)

Do Cannabinoids Confer Neuroprotection Against Epilepsy? An Overview
por: Capasso, Anna
Publicado: (2017)

SIRT1 Is Involved in the Neuroprotection of Pterostilbene Against Amyloid β 25–35-Induced Cognitive Deficits in Mice
por: Zhu, Lin, et al.
Publicado: (2022)

Dengzhanxixin Injection Ameliorates Cognitive Impairment Through a Neuroprotective Mechanism Based on Mitochondrial Preservation in Patients With Acute Ischemic Stroke
por: An, Haiting, et al.
Publicado: (2021)

Neuroprotective Effect and Possible Mechanisms of Berberine in Diabetes-Related Cognitive Impairment: A Systematic Review and Meta-Analysis of Animal Studies
por: Hao, Yanwei, et al.
Publicado: (2022)

Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy
por: Peres, Fernanda F., et al.
Publicado: (2016)

Cannabinoid Modulation of Memory Consolidation in Rats: Beyond the Role of Cannabinoid Receptor Subtype 1
por: Ratano, Patrizia, et al.
Publicado: (2017)

Activating Cannabinoid Receptor 2 Protects Against Diabetic Cardiomyopathy Through Autophagy Induction
por: Wu, Aiping, et al.
Publicado: (2018)

Components of the Endocannabinoid System and Effects of Cannabinoids Against Bone Diseases: A Mini-Review
por: Xin, Yuqi, et al.
Publicado: (2022)

Resveratrol and Neuroprotection: Impact and Its Therapeutic Potential in Alzheimer's Disease
por: Rahman, Md. Habibur, et al.
Publicado: (2020)

Should oncologists trust cannabinoids?
por: Creanga-Murariu, Ioana, et al.
Publicado: (2023)

Transcriptomic Study Reveals Recovery of Impaired Astrocytes Contribute to Neuroprotective Effects of Danhong Injection Against Cerebral Ischemia/Reperfusion-Induced Injury
por: Qian, Jing, et al.
Publicado: (2018)

Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders
por: Campos, Alline C., et al.
Publicado: (2017)

Editorial: Advanced chemical and material tools to enhance the therapeutic effect of drugs
por: Ihsan, Ayesha, et al.
Publicado: (2023)

Research progress on pleiotropic neuroprotective drugs for traumatic brain injury
por: Zhao, Qinghui, et al.
Publicado: (2023)

Impact of Cannabis, Cannabinoids, and Endocannabinoids in the Lungs
por: Turcotte, Caroline, et al.
Publicado: (2016)

Emerging Role of (Endo)Cannabinoids in Migraine
por: Leimuranta, Pinja, et al.
Publicado: (2018)

Antitumor Cannabinoid Chemotypes: Structural Insights
por: Morales, Paula, et al.
Publicado: (2019)

Can Prescribed Cannabinoids Substitute Cannabis?
por: Batalla, A.
Publicado: (2022)

Editorial: Cancer therapy: The challenge of handling a double-edged sword
por: Nurgali, Kulmira, et al.
Publicado: (2022)

Neuroprotective Effects of the Anti-cancer Drug Lapatinib Against Epileptic Seizures via Suppressing Glutathione Peroxidase 4-Dependent Ferroptosis
por: Jia, Ji-Ning, et al.
Publicado: (2020)

Modulation of type 1 cannabinoid receptor activity by cannabinoid by-products from Cannabis sativa and non-cannabis phytomolecules
por: Zagzoog, Ayat, et al.
Publicado: (2022)

Cannabinoid compounds in combination with curcumin and piperine display an anti-tumorigenic effect against colon cancer cells
por: Yüksel, Büşra, et al.
Publicado: (2023)

Neuroprotective Potency of Neolignans in Magnolia officinalis Cortex Against Brain Disorders
por: Zhu, Shun, et al.
Publicado: (2022)

Neuroprotective effects of açaí (Euterpe oleracea Mart.) against diabetic retinopathy
por: de Oliveira, Edwiges de Fátima, et al.
Publicado: (2023)

Protective Effects of Phyllanthus amarus Against Lipopolysaccharide-Induced Neuroinflammation and Cognitive Impairment in Rats
por: Alagan, Akilandeshwari, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3dc3e725h0lngmersuu63urhj5